Department of Pediatrics, Immunology and Nephrology, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.
Division of Didactics in Pediatrics, Medical University of Łódź, Łódź, Poland.
Ren Fail. 2021 Dec;43(1):62-70. doi: 10.1080/0886022X.2020.1860089.
Cystinuria is an inherited disorder that results in increased excretion of cystine in the urine. It accounts for about 1-2% of pediatric kidney stones. In this study, we sought to identify the clinical characteristics of patients with cystinuria in a national cohort.
This was a retrospective study involving 30 patients from the Polish Registry of Inherited Tubulopathies. Initial data and that from a 6-month follow-up were analyzed. Mutational analysis was performed by targeted Sanger sequencing and, if applicable, MLPA analysis was used to detect large rearrangements.
mutations were detected in 15 children (50%; 10 males, 5 females), mutations in 14 children (47%; 5 males, 9 females), and bigenic mutations in one male patient. The first clinical symptoms of the disease were detected at a median of 48 months of age (range 3-233 months). When individuals with different mutations were compared, there were no differences identified in gender, age of diagnosis, presence of UTI or urolithiasis, eGFR, calcium, or cystine excretion. The most common initial symptoms were urolithiasis in 26 patients (88%) and urinary tract infections in 4 patients (13%). Urological procedures were performed in 18 out of 30 (60%).
The clinical course of cystinuria is similar among patients, regardless of the type of genetic mutation. Most patients require surgery before diagnosis or soon after it. Patients require combined urological and pharmacological treatment for prevention of stone recurrence and renal function preservation.
胱氨酸尿症是一种遗传性疾病,导致尿液中胱氨酸排泄增加。它约占儿童肾结石的 1-2%。在这项研究中,我们试图在全国队列中确定胱氨酸尿症患者的临床特征。
这是一项回顾性研究,涉及波兰遗传性肾小管病登记处的 30 名患者。分析了初始数据和 6 个月的随访数据。通过靶向 Sanger 测序进行突变分析,如果适用,使用 MLPA 分析检测大片段重排。
在 15 名儿童(50%;10 名男性,5 名女性)中检测到突变,在 14 名儿童(47%;5 名男性,9 名女性)中检测到突变,在 1 名男性患者中检测到双基因突变。疾病的首发临床症状中位数为 48 个月(范围 3-233 个月)。当比较具有不同突变的个体时,在性别、诊断年龄、是否存在尿路感染或尿路结石、eGFR、钙或胱氨酸排泄方面没有差异。最常见的首发症状是 26 名患者(88%)的尿路结石和 4 名患者(13%)的尿路感染。30 名患者中有 18 名(60%)接受了泌尿科手术。
无论基因突变类型如何,胱氨酸尿症患者的临床病程相似。大多数患者在诊断前或诊断后不久需要手术。患者需要联合泌尿外科和药物治疗以预防结石复发和保护肾功能。